Skip to content
Axcess News – Lifestyle
Author:
Lakefront Biotherapeutics
Acquisition of Own Shares
September 22, 2026
Acquisition of Own Shares
September 15, 2026
Acquisition of Own Shares
September 8, 2026
Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
September 8, 2026
Acquisition of Own Shares
September 1, 2026
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
August 24, 2026
Lakefront Receives Transparency Notification from Bank of America
August 24, 2026
Acquisition of Own Shares
August 18, 2026
Acquisition of Own Shares
August 12, 2026
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update
August 10, 2026
1
2
3
Next Page
→